<DOC>
	<DOC>NCT00184951</DOC>
	<brief_summary>open-label, multiple dose, single-group, 12 week trial in HIV-infected patients with hyperlipidemia while using lopinavir/ritonavir; both male or female subjects.</brief_summary>
	<brief_title>Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients</brief_title>
	<detailed_description>To determine the effect of rosuvastatin on plasma lipids, lipoproteins, and endothelial function in HIV-infected patients on stable lopinavir/ritonavir therapy and to evaluate the safety of combined use of rosuvastatin and lopinavir/ritonavir. Also to determine the effect of lopinavir/ritonavir on the pharmacokinetics of rosuvastatin compared to historical controls an to determine the effect of rosuvastatin on the pk of lopinavir/ritonavir compared to historical controls and by intrapatient comparison.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>use of lopinavir 400mg/ritonavir 100mg bid &gt; 3months HIV1 RNA &lt;400cop/mL fasting total cholesterol &gt; 6.2mmol/L history of sensitivity/idiosyncrasy to the drug or compounds used history or current condition that might interfere with absorption,distribution metabolism or excretion pregnant or breastfeeding serum transaminase levels &gt;3 times upper limit of normal, creatinine clearance &lt;60ml/min fasting plasma triglycerides level &gt;8.0 mmol/L history of statinrelated rhabdomyolysis or inheritable muscle diseases in family history clinical symptoms of myopathy or abnormal CK level change in antiretroviral medication within the 3 months immediately preceding first dose of rosuvastatin use of any statin or fibrate within 6 weeks immediately preceding first dose of rosuvastatin concomitant use of medications that interfere with rosuvastatin or lopinavir pharmacokinetics active hepatobiliary or hepatic disease hypothyroidism alcohol abuse japanese or chinese patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>HIV</keyword>
</DOC>